Logo image
Gait analysis and quantitative drug effect evaluation in Parkinson disease by jointly EEG-EMG monitoring
Conference proceeding   Peer reviewed

Gait analysis and quantitative drug effect evaluation in Parkinson disease by jointly EEG-EMG monitoring

D De Venuto, Valerio Francesco Annese, G Defazio, VL Gallo and G Mezzina
Proceedings - 2017 12th IEEE International Conference on Design and Technology of Integrated Systems in Nanoscale Era, DTIS 2017, 7930171
12th IEEE International Conference on Design and Technology of Integrated Systems in Nanoscale Era, DTIS 2017 (Palma de Mallorca)
2017
Handle:
https://hdl.handle.net/10863/53901

Abstract

This work addresses the rising need for a diagnostic tool for the evaluation of the effectiveness of a drug treatment in Parkinson disease, allowing the physician to monitor of the patient gait at home and to shape the treatment on the individual peculiarity. In aim, we present a cyber-physical system for real-time processing EEG and EMG signals. The wearable and wireless system extracts the following indexes: (i) typical activation and deactivation timing of single muscles and the duty cycle in a single step (ii) typical and maximum co-contractions, as well as number of co-contraction/s. The indexes are validated by using Movement Related Potentials (MRPs). The signal processing stage is implemented on Altera Cyclone V FPGA. In the paper, we show in vivo measurements by comparing responses before and after the drug (Levodopa) treatment. The system quantifies the effect of the Levodopa treatment detecting: (i) a 17% reduction in typical agonist-antagonist co-contractions time (ii) 23.6% decrease in the maximum co-contraction time (iii) 33% decrease in number of critical co-contraction. Brain implications shows a mean reduction of 5% on the evaluated potentials. © 2017 IEEE.
url
https://doi.org/10.1109/DTIS.2017.7930171View

Details

Metrics

1 Record Views
Logo image